Skip to main content
ABIVAX Société Anonyme (EPA:ABVX)
France flag France · Delayed Price · Currency is EUR
94.90
+0.90 (0.96%)
At close: Mar 9, 2026

ABIVAX Société Anonyme Revenue

ABIVAX Société Anonyme had revenue of 639.00K EUR in the quarter ending September 30, 2025, a decrease of -88.61%. This brings the company's revenue in the last twelve months to 5.31M, down -42.89% year-over-year. In the year 2024, ABIVAX Société Anonyme had annual revenue of 10.79M with 135.94% growth.

Revenue (ttm)
5.31M
Revenue Growth
-42.89%
P/S Ratio
1,377.52
Revenue / Employee
79.27K
Employees
67
Market Cap
7.32B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202410.79M6.22M135.94%
Dec 31, 20234.57M69.00K1.53%
Dec 31, 20224.51M302.00K7.19%
Dec 31, 20214.20M4.19M29,921.43%
Dec 31, 202014.00K21.00K-300.00%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Nanobiotix 10.16M
DBV Technologies 4.69M
Inventiva 16.97M
Valneva SE 179.91M
MedinCell 32.44M
Genfit 45.13M
Cellectis 70.36M
Transgene 7.58M
Revenue Rankings

ABIVAX Société Anonyme News

More News